Microchips in Medicine Market Players:
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Applied Microarrays Inc.
- RELX Group
- QIAGEN
- Agilent Technologies, Inc.
- INTROMEDIC
- Otsuka America Pharmaceutical, Inc.
- Medtronic Plc
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of microchips in medicine is evaluated at USD 1.35 billion.
The global microchips in medicine market size exceeded USD 1.27 billion in 2025 and is set to expand at a CAGR of over 6.7%, surpassing USD 2.43 billion revenue by 2035.
By 2035, North America is anticipated to secure a 35% share in the Microchips in Medicine Market, impelled by rising healthcare spending.
Key players in the market include Thermo Fisher Scientific Inc., Applied Microarrays Inc., RELX Group, QIAGEN, Agilent Technologies, Inc., INTROMEDIC, Otsuka America Pharmaceutical, Inc., Medtronic Plc, Illumina, Inc., Bio-Rad Laboratories, Inc.
